This article is part of the May 2021 Spotlight US series, "How the pandemic has changed US healthcare marketing." Read more
Genentech is a biotechnology company on the forefront of treating people with hemophilia, a medical condition that significantly reduces the ability of blood to clot, through its Hemlibra brand of prescription medicine.